Avacta adds range of rapid tests with Coris Bioconcept acquisition
Avacta Group has acquired Coris Bioconcept for £7.4 million and an extra £3 million payout based on future business performance.
If you are not happy with the results below please do another search
Avacta Group has acquired Coris Bioconcept for £7.4 million and an extra £3 million payout based on future business performance.